Other Transaction Agreement HQ08452390004
Award Date
2/10/23
Potential Completion Date
8/29/24
Potential Value
$2.9M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
Office of the Secretary of Defense
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
AC33 - National Defense R&D Services; Defense-Related Activities; Experimental Development
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Seattle, WA 98102, USA
Solicitation Procedures
Program Solicitation
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Access To Advanced Health Institute (AAHI), doing business as Aahi, Idri, and Infectious Disease Research Institute. The $2,980 contract is for infectious disease research and development, specifically related to vaccine adjuvants. AAHI is a non-profit biotech research institute that combines academic...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute in Seattle, Washington. The contract is for in vitro characterization of anti-mycobacterial activity, as part of the larger In Vitro Antimicrobial Assessments 2011-2018 contract vehicle. The contract has a ceiling value of...
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...
This is a $18,576,013.05 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant infections, and emerging infectious diseases under Broad Agency...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $4,140 contract is for infectious disease research functions and does not have a set-aside designation. AAHI, which also operates under the names Aahi, Idri, and Infectious Disease Research Institute, conducts research and...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $638,080 contract is for in vitro assessment of antimicrobial activity, under the In Vitro Antimicrobial Assessments 2011-2018 master IDIQ contract. The period of performance is from November 4, 2016 to October 31, 2017. AAHI is a prime contractor experienced in...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $780,764 firm fixed price purchase order contract to Access To Advanced Health Institute, doing business as Aahi, Idri, Infectious Disease Research Institute, located in Rockville, Maryland. Under the contract, Idri will provide investigational products GLA-SE adjuvant formulation and lyophilized ID93 from Idri for clinical trials funded by NIAID's Division of AIDS. As the prime contractor, Idri...
This is a $18,844,434.24 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute, for the advanced development and clinical evaluation of a synthetic intranasal Entamoeba histolytica vaccine containing an adjuvant. The contract does not have a set-aside designation. The contract involves several subcontractors, including the University of Wisconsin System,...
This is a $748,885 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute based in Seattle, Washington. The contract is for research and development of intranasal administration of RNA vaccines against respiratory pathogens. The contract was awarded under an Ease Broad Agency Announcement (EZ-BAA) issued by the Division of Research, Innovation, and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite...